RxMen Secures Rs 5 Crore Seed Funding for Men's Health Revolution

Investorsync desk1 min read

Deal sheet

Rs 5 Crore

Stage
Seed
Sector
HealthTech
Announced
4 September 2025

RxMen has raised Rs 5 crore in seed funding led by Inflection Point Ventures (IPV), with participation from SPA Family Ventures, Seven Square Ventures, and a grant from Prosus Group.

Founded by Shailja Mittal in 2023, Delhi, RxMen is building a clinic-led men’s health platform offering root-cause treatment for sexual health, hormones, skin, stress, and sleep.

The fresh capital will be used for brand building, launching RxMen products, and opening co-branded clinics.

  • In 20 months, it has grown 100x in revenue, reporting an MRR of $70,000 (Aug 2025) and projecting an ARR of $1.7M by FY26.
  • It has delivered 30,000+ consultations, handling 6,000 monthly via 30 specialists in urology, psychiatry, sexology, and therapy.

Source: company announcement. First posted on the Investorsync LinkedIn page.

From InvestorDB

Investors in this round.

Keep reading

The Sync Report

All Rounds